Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

HAE

HAEMONETICS CORP

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 313143Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2026
$1.33B
Net Income FY2026
$0.10B
EPS (Basic, as reported)
$2.06
Net Margin FY2026
7.3%
ROE FY2026
12.2%
Total Equity
$0.80B
Shares Out
45M
Business description

HAEMONETICS CORP — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 886 → 1,334 +4.7% CAGR
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue8869049689888709931,1691,3091,3611,334
Cost of revenue(508)(492)(550)(504)(473)(488)(554)(618)(612)(546)
Gross profit378412418485398506615692749788
Research & development(38)(39)(36)(31)(33)(47)(50)(54)(63)(60)
Selling, general & administrative(302)(317)(298)(300)(274)(340)(377)(432)(437)(442)
Total operating expenses(398)(356)(334)(381)(308)(425)(459)(527)(527)(631)
Operating income(19)56841039081156165222157
Interest expense—(8)(13)(13)(9)(6)(13)(19)(36)(19)
Interest & investment income——————————
Other income (expense), net(8)(5)(10)(16)(17)(17)(15)(13)(10)(29)
Pre-tax income(27)6074877364141152212128
Income tax expense(1)(14)(19)(11)(7)(20)(26)(34)(44)(31)
Net income(26)465577794311511816897
EPS — basic($0.51)$0.86$1.07$1.51$1.57$0.85$2.27$2.32$3.33$2.06
EPS — diluted($0.51)$0.85$1.04$1.48$1.55$0.84$2.24$2.29$3.31$2.05
Shares outstanding — basic (M)52535251515151515047
Shares outstanding — diluted (M)52545352515151515147

Showing the latest 10 of 18 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.